| Rank | Ticker | Price | Market Cap | Analyst Rating | Avg Volume |
|---|---|---|---|---|---|
#1 | DBD | $68.99 | $2.5B | Strong Buy | $214.6K |
#2 | SGHC | $9.42 | $5.8B | Strong Buy | $2.1M |
#3 | ORLA | $15.03 | $6.6B | Buy | $2.5M |
#4 | VICR | $159.80 | $6.8B | Strong Buy | $649.8K |
#5 | IVT | $29.31 | $2.2B | Buy | $496.7K |
#6 | FLR | $46.28 | $7.3B | Buy | $2.6M |
#7 | NGD | $10.02 | $5.3B | Buy | $21.9M |
#8 | WSC | $19.98 | $3.6B | Buy | $1.8M |
#9 | FSM | $9.71 | $3.5B | Buy | $8.5M |
#10 | AIR | $106.25 | $4.3B | Strong Buy | $656.4K |
#11 | AZZ | $124.96 | $3.3B | Buy | $157.4K |
#12 | ERO | $33.61 | $3.0B | Strong Buy | $2.3M |
#13 | RIOT | $15.46 | $6.4B | Strong Buy | $20.5M |
#14 | TX | $41.92 | $7.3B | Buy | $217.4K |
#15 | GEO | $16.01 | $2.2B | Strong Buy | $1.8M |
#16 | LXP | $49.51 | $3.0B | Buy | $474.6K |
#17 | MC | $71.80 | $5.3B | Buy | $762.4K |
#18 | FAF | $63.01 | $6.3B | Buy | $1.1M |
#19 | SHAK | $88.64 | $3.9B | Buy | $1.6M |
#20 | RNW | $5.42 | $2.7B | Buy | $902.3K |
#21 | HBM | $23.75 | $9.1B | Strong Buy | $6.2M |
#22 | OPLN | $30.06 | $3.2B | Buy | $764.1K |
#23 | DUOL | $134.05 | $8.4B | Buy | $2.1M |
#24 | CECO | $67.59 | $2.1B | Strong Buy | $241.3K |
#25 | GLNG | $40.57 | $4.1B | Strong Buy | $1.0M |
#26 | KRYS | $280.54 | $6.3B | Strong Buy | $306.9K |
#27 | MARA | $9.43 | $4.5B | Buy | $41.1M |
#28 | AEIS | $260.24 | $9.8B | Strong Buy | $865.9K |
#29 | CGAU | $16.68 | $3.6B | Buy | $2.1M |
#30 | MOS | $27.47 | $8.3B | Buy | $7.5M |
#31 | CMC | $77.16 | $6.4B | Buy | $1.4M |
#32 | HHH | $81.67 | $4.8B | Buy | $328.4K |
#33 | DAVE | $164.44 | $2.5B | Strong Buy | $533.2K |
#34 | KGS | $42.14 | $3.5B | Strong Buy | $1.3M |
#35 | MGNI | $14.41 | $2.2B | Strong Buy | $2.2M |
#36 | ADMA | $17.27 | $4.7B | Strong Buy | $2.4M |
#37 | DOCN | $55.32 | $4.6B | Buy | $2.8M |
#38 | ESE | $228.38 | $5.2B | Strong Buy | $175.3K |
#39 | MNDY | $114.78 | $7.4B | Strong Buy | $1.5M |
#40 | UPWK | $20.04 | $2.6B | Buy | $2.2M |
#41 | LEVI | $19.84 | $9.1B | Strong Buy | $2.2M |
#42 | PACS | $34.00 | $6.5B | Strong Buy | $1.1M |
#43 | TMDX | $133.31 | $4.6B | Buy | $790.8K |
#44 | FRPT | $69.22 | $3.4B | Buy | $1.1M |
#45 | MYRG | $249.07 | $3.9B | Buy | $203.6K |
#46 | GNW | $8.35 | $3.3B | Buy | $4.0M |
#47 | LC | $16.90 | $2.0B | Buy | $2.5M |
#48 | SWX | $82.74 | $5.9B | Strong Buy | $514.1K |
#49 | CWK | $16.45 | $3.5B | Buy | $1.5M |
#50 | CAVA | $60.69 | $7.7B | Buy | $3.6M |
The FinQuota filters have identified what they believe to be the "Best Mid Cap Stocks to Buy (1 February 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.